Dual inhibition of SRC and Aurora kinases induces postmitotic attachment defects and cell death

V Ratushny1, H B Pathak, N Beeharry

  • 1Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Oncogene
|July 26, 2011
PubMed

Insights

Combining Aurora and SRC kinase inhibitors shows potent synergy in killing cancer cells, particularly those with mitotic defects. This targeted approach selectively removes aneuploid cells, offering a promising new cancer therapy strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • SRC family kinases (SFKs) drive tumor invasion and metastasis.
  • Aurora kinase A (AURKA) overexpression causes aneuploidy and chromosomal instability.
  • Both SRC and AURKA are validated therapeutic targets in cancer treatment.

Purpose of the Study:

  • To investigate the synergistic effects of combining Aurora and SRC kinase inhibitors.
  • To determine the mechanisms underlying the synergy between these inhibitors.
  • To evaluate the potential of this combination therapy in ovarian and colorectal cancers.

Main Methods:

  • Utilized ovarian and colorectal cancer cell lines and normal ovarian epithelial cells.
  • Administered combinations of Aurora and SRC kinase inhibitors.
  • Assessed cell viability, mitotic progression, and aneuploidy.
  • Investigated protein interactions and phosphorylation events between SRC and AURKA.

Main Results:

  • Demonstrated potent synergy between Aurora and SRC inhibitors in cancer cell lines, but not normal cells.
  • Observed selective killing of cells with aberrant mitosis, postmitotic reattachment defects, and aneuploidy.
  • Showed that combined inhibition potentiated dasatinib-induced loss of activated SRC.
  • Confirmed physical interaction and mutual cross-phosphorylation between SRC and AURKA, enhancing SRC activity.

Conclusions:

  • Combination therapy targeting SRC and Aurora kinases exhibits potent anti-cancer effects.
  • The synergy is linked to the selective elimination of aneuploid cells and cells with mitotic defects.
  • Combined inhibition of SRC and AURKA represents a promising therapeutic strategy for cancer treatment.

Related Concept Videos

Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Attachment of Sister Chromatids02:57

Attachment of Sister Chromatids

As cells progress into mitosis, the nuclear envelope breaks down, and the condensed chromosomes are exposed to the array of bipolar microtubules of the mitotic spindle. The kinetochore, a large, disc-shaped protein complex, is present at the centromere region of the sister chromatids and acts as a binding site for the microtubules.  Usually, the plus-end of a single microtubule is embedded within the kinetochore. However, some kinetochores first establish lateral contact with the side-wall of a...
Meiosis II02:02

Meiosis II

Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...